ibSium® is a proprietary, patented probiotic yeast strain used in nutraceutical and dietary supplement applications, developed by Lesaffre for digestive comfort and gut balance support.Key Benefits:• Registered strain Saccharomyces cerevisiae CNCM I-3856, exclusive to Lesaffre, developed through a dedicated clinical substantiation program• Positioned for digestive comfort, bloating relief, abdominal comfort, and bowel habit balance, relevant to irritable bowel and functional digestive discomfort formulations• Yeast-based probiotic format: naturally resistant to gastric acid and bile salts, no encapsulation or protective coating required, unaffected by antibiotic therapy• Transient, non-colonizing mode of action, supporting a balanced gut microbiota without permanent strain implantation• US GRAS (FDA 21 CFR §172.896) and EU QPS status, non-GMO, gluten-free, lactose-free, suitable for Kosher, Halal, vegetarian and vegan diets• High stability: 18 months at ambient temperature, no cold chain required[HJ1.1]• Available in powders and vermicelli• Recommended dosage: 4 billion CFU/day (1 to 2 capsules)• Not recommended for individuals in fragile health conditions (severely immunocompromised individuals, critically ill or extremely premature infants), consistent with standard probiotic yeast precautions[HJ2.1][TU2.2]• Produced by Gnosis by Lesaffre and distributed by Safic-AlcanTypical Applications:Probiotic yeast / digestive comfort probiotic / gut microbiota support ingredient for dietary supplements and nutraceutical formulations targeting occasional digestive discomfort, bloating, irregular transit, and general gut wellness. Suitable for capsules, sachets, and stick pack formats. Complementary ingredient for gut-health product lines, including formulations supporting digestive comfort alongside GLP-1 weight-management treatments, and for combination formulas with complementary probiotic strains such as Lactobacillus rhamnosus GG.
